Published in Pharmacol Res on November 01, 1997
Cellular and molecular actions of Methylene Blue in the nervous system. Med Res Rev (2011) 1.22
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol (2000) 1.02
Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue. Am J Pharmacol Toxicol (2008) 1.01
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model. Neuropsychiatr Dis Treat (2005) 0.97
Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology (Berl) (2006) 0.95
Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies. J Neural Transm (Vienna) (2007) 0.85
Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders. Neuropsychiatry (London) (2012) 0.79
Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice. Psychopharmacology (Berl) (2007) 0.78
Neuroprotective effects of Nigella sativa extracts during germination on central nervous system. Pharmacogn Mag (2015) 0.75
Brain region-specific effects of cGMP-dependent kinase II knockout on AMPA receptor trafficking and animal behavior. Learn Mem (2016) 0.75
Methylene blue inhibits function of the 5-HT transporter. Br J Pharmacol (2012) 0.75
Nitric Oxide Synthase Inhibitors as Antidepressants. Pharmaceuticals (Basel) (2010) 0.75
Methylene blue and its analogues as antidepressant compounds. Metab Brain Dis (2017) 0.75
Hemoptysis: a retrospective analysis of 108 cases. Respir Med (2002) 1.09
Cardiac or pulmonary dyspnea in patients admitted to the emergency department. Respir Med (2003) 0.94
Thorax and lung injuries arising from the two earthquakes in Turkey in 1999. Chest (2001) 0.89
Evaluation of pulmonary complications of radiotherapy in breast cancer patients. J BUON (2007) 0.75